Bovie Medical Co. (NYSE:BVX) shares were up 3% during trading on Monday . The stock traded as high as $4.50 and last traded at $4.43, with a volume of 115,843 shares changing hands. The stock had previously closed at $4.30.

Several research analysts have commented on BVX shares. Zacks Investment Research raised shares of Bovie Medical from a “sell” rating to a “hold” rating in a report on Tuesday, July 19th. JMP Securities reissued an “outperform” rating and issued a $5.00 price target on shares of Bovie Medical in a report on Wednesday, August 3rd.

The company’s market cap is $114.21 million. The firm’s 50 day moving average is $2.82 and its 200-day moving average is $2.05.

In related news, insider John J. Mccarthy III acquired 90,750 shares of the firm’s stock in a transaction dated Wednesday, August 17th. The stock was purchased at an average cost of $3.30 per share, with a total value of $299,475.00. Following the completion of the acquisition, the insider now directly owns 115,750 shares of the company’s stock, valued at $381,975. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.